DeepPurpose: a Deep Learning Library for Drug-Target Interaction Prediction
Not on the map. Why?
Abstract (arXiv)
Accurate prediction of drug-target interactions (DTI) is crucial for drug discovery. Recently, deep learning (DL) models for show promising performance for DTI prediction. However, these models can be difficult to use for both computer scientists entering the biomedical field and bioinformaticians with limited DL experience. We present DeepPurpose, a comprehensive and easy-to-use deep learning library for DTI prediction. DeepPurpose supports training of customized DTI prediction models by implementing 15 compound and protein encoders and over 50 neural architectures, along with providing many other useful features. We demonstrate state-of-the-art performance of DeepPurpose on several benchmark datasets.
Key facts. Cited by 5 papers in the map (data through 7 Oct 2026). First posted on arXiv 19 Apr 2020.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2021: 4; 2022: 1.
5 papers.
- 2021ChemRL-GEM: Geometry Enhanced Molecular Representation Learning for Property Predictioncited by 204
- 2021SafeDrug: Dual Molecular Graph Encoders for Recommending Effective and Safe Drug Combinationscited by 51
- 2022De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learningcited by 4
- 2021Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19cited by 1
- 2021Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidatescited by 0
- 2022De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning21 May 2022
- 2021ChemRL-GEM: Geometry Enhanced Molecular Representation Learning for Property Prediction11 Jun 2021
- 2021Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates7 May 2021
- 2021SafeDrug: Dual Molecular Graph Encoders for Recommending Effective and Safe Drug Combinations5 May 2021
- 2021Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-199 Feb 2021